Local Expression of Indoleamine 2,3-Dioxygenase Protects Engraftment of Xenogeneic Skin Substitute

Bell, 1979, Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro, Proc Natl Acad Sci USA, 76, 1274, 10.1073/pnas.76.3.1274 Bishop, 1999, An in vitro model of angiogenesis: basic features, Angiogenesis, 3, 335, 10.1023/A:1026546219962 Black, 1998, In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent, FASEB J, 12, 1331, 10.1096/fasebj.12.13.1331 Boyce, 1995, Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitues in arrythmic mice, J Invest Dermatol, 104, 345, 10.1111/1523-1747.ep12665374 Clemens, 2001, Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis, Prog Mol Subcell Biol, 27, 57, 10.1007/978-3-662-09889-9_3 Crosby, 2000, Regulation of hemoglobin synthesis and proliferation of differentiation erythroid cells by heme-regulated eIF-2 alpha kinase, Blood, 96, 3241, 10.1182/blood.V96.9.3241 Daley-Yates, 1988, Pulmonary indoleamine 2,3-dioxygenase activity and its significance in the response of rats, mice, and rabbits to oxidative stress, Toxicol Appl Pharmacol, 96, 222, 10.1016/0041-008X(88)90082-8 Davison, 1996, Regulation of angiogenesis and wound repair, 79 Erdag, 2004, Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts, Cell Transplant, 13, 701, 10.3727/000000004783983594 Friberg, 2002, Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection, Int J Cancer, 101, 151, 10.1002/ijc.10645 Frumento, 2002, Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase, J Exp Med, 196, 459, 10.1084/jem.20020121 Ghahary, 2000, Mannose-6-phosphate/IGF-II receptors mediate the effects of IGF-1-induced latent transforming growth factor beta 1 on expression of type I collagen and collagenase in dermal fibroblasts, Growth Factors, 17, 167, 10.3109/08977190009001066 Hayashi, 2004, Inhibition of experimental asthma by indoleamine 2,3-dioxygenase, J Clin Invest, 114, 270, 10.1172/JCI21275 Hultman, 1996, Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second-set rejection, J Trauma, 41, 51, 10.1097/00005373-199607000-00009 Isik, 2003, Prolongation of skin xenograft survival with modified cultured fibroblasts, Plast Reconstr Surg, 111, 275, 10.1097/00006534-200301000-00046 Lee, 2002, Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division, Immunology, 107, 452, 10.1046/j.1365-2567.2002.01526.x Li, 2004, Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment, Hum Immunol, 65, 114, 10.1016/j.humimm.2003.11.004 Li, 2004, Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor, J Invest Dermatol, 122, 953, 10.1111/j.0022-202X.2004.22409.x Lorimier, 1996, Tissue origin and extracellular matrix control neutral protease activity in human fibroblast three-dimensional cultures, J Cell Physiol, 168, 188, 10.1002/(SICI)1097-4652(199607)168:1<188::AID-JCP23>3.0.CO;2-2 Munn, 1999, Inhibition of T cell proliferation by macrophage tryptophan catabolism, J Med Exp, 189, 1363, 10.1084/jem.189.9.1363 Munn, 2005, GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase, Immunity, 22, 633, 10.1016/j.immuni.2005.03.013 Munn, 2004, Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes, J Clin Invest, 114, 280, 10.1172/JCI200421583 Munn, 1998, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science, 281, 1191, 10.1126/science.281.5380.1191 Narumiya, 2001, Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia, Hypertens Pregnancy, 20, 185, 10.1081/PRG-100106968 Nehls, 1998, Contact-dependent inhibition of angiogenesis by cardiac fibroblasts in three-dimension fibrin gels in vitro: implications for microvascular network remodeling and coronary collateral formation, Cell Tissue Res, 293, 479, 10.1007/s004410051140 Rao, 2004, Coupling endoplasmic reticulum stress to the cell death program, Cell Death Differ, 11, 372, 10.1038/sj.cdd.4401378 Rissau, 1997, Mechanisms of angiogenesis, Nature, 386, 671, 10.1038/386671a0 Sahota, 2004, Approaches to improve angiogenesis in tissue-engineered skin, Wound Rep Regen, 12, 635, 10.1111/j.1067-1927.2004.12608.x Sahota, 2003, Development of a reconstructed human skin model for angiogenesis, Wound Rep Regen, 11, 275, 10.1046/j.1524-475X.2003.11407.x Schaffer, 1996, Cell biology of wound healing, Int Rev Cytol, 169, 151, 10.1016/S0074-7696(08)61986-5 Schmidt, 2003, A new murine model of islet xenograft rejection: graft destruction is dependent on a major histocompatibility-specific interaction between T-cells and macrophages, Diabetes, 52, 1111, 10.2337/diabetes.52.5.1111 Schneider, 2004, Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions, Hum Gene Ther, 7, 669 Sengar, 1996, Molecular framework for angiogenesis, Am J Pathol, 149, 1 Sher, 1983, Acceptance of allogeneic fibroblasts in skin equivalent transplants, Transplantation, 36, 552, 10.1097/00007890-198311000-00015 Sood, 2000, A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha, Genetics, 154, 787, 10.1093/genetics/154.2.787 Sun, 1989, Indoleamine 2,3-dioxygenase – a new antioxidant enzyme, Mater Med Pol, 21, 244 Supp, 2002, Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes, J Burn Care Rehab, 23, 10, 10.1097/00004630-200201000-00004 Supp, 2000, Enhanced vascularization of cultured skin substitutes genetically modified to overexpress vascular endothelial growth factor, J Invest Dermatol, 114, 5, 10.1046/j.1523-1747.2000.00824.x Supp, 2002, Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice, FASEB J, 16, 797, 10.1096/fj.01-0868com Takikawa, 1988, Mechanism of interferon-γ action: characterization of indoleamine 2,3-dioxygenase in cultured human cells by interferon-γ and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity, J Biol Chem, 263, 2041, 10.1016/S0021-9258(19)77982-4 Taylor, 1991, Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism, FASEB J, 5, 2516, 10.1096/fasebj.5.11.1907934 Terness, 2002, Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase expressing dendritic cells: mediation of suppression by tryptophan metabolites, J Exp Med, 196, 447, 10.1084/jem.20020052 Uyttenhove, 2003, Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase, Nat Med, 9, 1269, 10.1038/nm934 Volpin, 1971, Isolation and characterization of the cyanogen bromide peptides from the α1 and α2 chains of acid-soluble bovine skin collagen, Biochemistry, 10, 1751, 10.1021/bi00786a003 Wek, 1989, Juxtaposition of domains homologous to protein kinases and histidyl–tRNA synthetases in GCN2 protein suggests a mechanism for coupling GCN4 expression to amino acid availability, Proc Natl Acad Sci USA, 86, 4579, 10.1073/pnas.86.12.4579 Yoshida, 1996, Differential endothelial migration and proliferation top basic fibroblast growth factor and vascular endothelial growth factor, Growth Factors, 13, 57, 10.3109/08977199609034566 Young, 1996, Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice, J Burn Care Rehab, 17, 305, 10.1097/00004630-199607000-00005 Zhang, 2002, The GCN2 eIF2 alpha kinase is required for adaptation to amino acid deprivation in mice, Mol Cell Biol, 22, 6681, 10.1128/MCB.22.19.6681-6688.2002